Skip to content
Screener

Medpace Holdings, Inc. MEDP Total costs & expenses

Total costs & expenses at other companies

Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$663.4M-36.2%
Exelixis logo
ExelixisEXEL
$380.28M+7.2%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Segments

By segment

See full
Reportable Segment$560.51M+17.5%

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.41B+35.7%
Enterprise value$16.05B+31.6%
P/E33.4×+4.5×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
(Amounts in thousands, except per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Selling, general and administrative48,10346,66496,020104,561
Depreciation6,5556,77713,30613,471
Amortization155237310473
Total operating expenses560,507476,9761,125,608922,023
Income from operations146,824126,335288,327239,858
Other income (expense), net:
Miscellaneous (expense) income, net(147)(2,875)824(4,691)
Interest income, net4,9861,07810,1037,541

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s total costs & expenses?
Medpace Holdings, Inc. (MEDP) reported total costs & expenses of $560.51M in Q2 2026.
How has Medpace Holdings, Inc.'s total costs & expenses changed year-over-year?
Medpace Holdings, Inc.'s total costs & expenses increased by 17.5% year-over-year, from $476.98M to $560.51M.
What is the long-term trend for Medpace Holdings, Inc.'s total costs & expenses?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s total costs & expenses has grown at a 20.6% compound annual growth rate (CAGR), from $943.76M to $2B.
What does total costs & expenses mean?
Total costs and expenses represent the sum of all operating costs incurred to generate revenue, including direct service costs, administrative overhead, and non-cash charges. This metric provides a comprehensive view of the company's total operational burden.

Ask your AI about Medpace Holdings, Inc.'s total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude